ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication

Although podophyllotoxin (POD) demonstrates high efficiency to inhibit various cancers, its clinic application is limited to poor bioavailability. Nanoparticles derived from homodimeric prodrugs with high drug loading potential are emerging as promising nanomedicines. However, complete intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Bingfeng, Zhou, Dangxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583822/
https://www.ncbi.nlm.nih.gov/pubmed/34747277
http://dx.doi.org/10.1080/10717544.2021.1995076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583822/
https://www.ncbi.nlm.nih.gov/pubmed/34747277
http://dx.doi.org/10.1080/10717544.2021.1995076

Ejemplares similares